GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Insulet Corp (FRA:GOV) » Definitions » E10

Insulet (FRA:GOV) E10 : €0.04 (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Insulet E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Insulet's adjusted earnings per share data for the three months ended in Mar. 2024 was €0.672. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.04 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was 57.30% per year. During the past 5 years, the average E10 Growth Rate was 39.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Insulet was 57.30% per year. The lowest was 18.50% per year. And the median was 42.90% per year.

As of today (2024-05-17), Insulet's current stock price is €170.40. Insulet's E10 for the quarter that ended in Mar. 2024 was €0.04. Insulet's Shiller PE Ratio of today is 4,260.00.

During the past 13 years, the highest Shiller PE Ratio of Insulet was 4514.00. The lowest was 4125.00. And the median was 4156.25.


Insulet E10 Historical Data

The historical data trend for Insulet's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Insulet E10 Chart

Insulet Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.75 -0.52 -0.50 -0.42 -0.05

Insulet Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.36 -0.30 -0.19 -0.05 0.04

Competitive Comparison of Insulet's E10

For the Medical Devices subindustry, Insulet's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Insulet's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Insulet's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Insulet's Shiller PE Ratio falls into.



Insulet E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Insulet's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.672/131.7762*131.7762
=0.672

Current CPI (Mar. 2024) = 131.7762.

Insulet Quarterly Data

per share eps CPI Adj_EPS
201406 -0.390 100.560 -0.511
201409 -0.147 100.428 -0.193
201412 -0.081 99.070 -0.108
201503 -0.194 99.621 -0.257
201506 -0.241 100.684 -0.315
201509 -0.303 100.392 -0.398
201512 -0.441 99.792 -0.582
201603 -0.198 100.470 -0.260
201606 -0.071 101.688 -0.092
201609 -0.045 101.861 -0.058
201612 -0.152 101.863 -0.197
201703 -0.159 102.862 -0.204
201706 -0.116 103.349 -0.148
201709 -0.034 104.136 -0.043
201712 -0.101 104.011 -0.128
201803 -0.091 105.290 -0.114
201806 -0.026 106.317 -0.032
201809 0.026 106.507 0.032
201812 0.141 105.998 0.175
201903 0.062 107.251 0.076
201906 0.018 108.070 0.022
201909 0.009 108.329 0.011
201912 0.072 108.420 0.088
202003 -0.027 108.902 -0.033
202006 0.195 108.767 0.236
202009 0.144 109.815 0.173
202012 -0.214 109.897 -0.257
202103 0.000 111.754 0.000
202106 -0.307 114.631 -0.353
202109 0.153 115.734 0.174
202112 0.372 117.630 0.417
202203 0.363 121.301 0.394
202206 -0.473 125.017 -0.499
202209 -0.081 125.227 -0.085
202212 0.227 125.222 0.239
202303 0.318 127.348 0.329
202306 0.360 128.729 0.369
202309 0.693 129.860 0.703
202312 1.320 129.419 1.344
202403 0.672 131.776 0.672

Add all the adjusted EPS together and divide 10 will get our e10.


Insulet  (FRA:GOV) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Insulet's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=170.40/0.04
=4,260.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Insulet was 4514.00. The lowest was 4125.00. And the median was 4156.25.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Insulet E10 Related Terms

Thank you for viewing the detailed overview of Insulet's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Insulet (FRA:GOV) Business Description

Traded in Other Exchanges
Address
100 Nagog Park, Acton, MA, USA, 01720
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 360,000 insulin-dependent diabetics are using it worldwide.

Insulet (FRA:GOV) Headlines

No Headlines